Patent · US Active

Amorphous salt of a macrocyclic inhibitor of HCV

US9321758B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Peter Jozef Maria Van Remoortere · Princeton, US
Roger Petrus Gerebern Vandecruys · Westerlo, BE
Herman Augustinus De Kock · Arendonk, BE

Key dates

Filing date	Feb 26, 2010
Grant date	Apr 26, 2016
Priority date	—
Expiry date	Oct 28, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4725
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The amorphous form of the sodium salt of the macrocyclic inhibitor of HCV of formula:as well as processes for manufacturing this salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.